Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -193,914 | -119,920 | -59,865 | -123,156 | -80,682 |
| Depreciation Amortization | 29,215 | 19,232 | 9,662 | 27,886 | 22,503 |
| Accounts receivable | 0 | 0 | N/A | 4,959 | 6,195 |
| Accounts payable and accrued liabilities | 6,697 | 3,656 | 11,098 | -9,514 | -2,681 |
| Other Working Capital | -8,547 | -5,864 | -4,538 | -43,307 | -47,580 |
| Other Operating Activity | 7,240 | 4,298 | -6,180 | -118,663 | -120,523 |
| Operating Cash Flow | $-159,309 | $-98,598 | $-49,823 | $-261,795 | $-222,768 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 500 | 500 | 500 | 12,665 | 9,893 |
| Net Acquisitions | N/A | N/A | N/A | 166,383 | 166,383 |
| Investing Cash Flow | $500 | $500 | $500 | $179,048 | $176,276 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,500 | 9,500 | 9,500 | 163,000 | 0 |
| Common Stock Issued | 173,157 | 167,694 | 672 | 15,608 | 15,595 |
| Other Financing Activity | -280 | -280 | -280 | -5,975 | -511 |
| Financing Cash Flow | $182,377 | $176,914 | $9,892 | $172,633 | $15,084 |
| Exchange Rate Effect | 1,728 | 1,968 | 856 | -1,766 | -1,374 |
| Beginning Cash Position | 245,020 | 245,020 | 245,020 | 156,900 | 156,900 |
| End Cash Position | 270,316 | 325,804 | 206,445 | 245,020 | 124,118 |
| Net Cash Flow | $25,296 | $80,784 | $-38,575 | $88,120 | $-32,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159,309 | -98,598 | -49,823 | -261,795 | -222,768 |
| Capital Expenditure | 0 | 0 | N/A | -7 | -7 |
| Free Cash Flow | -159,309 | -98,598 | -49,823 | -261,802 | -222,775 |